New Hope for HER2-Negative Breast Cancer: PARP Inhibitors Explained

PARP inhibitors are changing the treatment landscape for certain types of breast cancer. In this video, our cancer specialists break down how a patient can determine if this type of treatment can work for them – and, if so, how to access it. Watch the video to hear what precision cancer medicine specialist, Alex Rolland, and precision cancer medicine advocacy expert, Michelle Morand, share about this exciting update. These FDA-approved PARP inhibitors can work well for HER2-negative breast cancers with a BRCA mutation, both in high-risk early-stage and metastatic settings. These therapies are used after prior chemotherapy, and one of the treatments is also approved for earlier-stage disease. In this discussion, Alex and Michelle cover: ✅ What PARP inhibitors are and how they work ✅ The difference between germline and somatic BRCA mutations ✅ Which breast cancer patients may benefit from PARP inhibitors ✅ What genetic and molecular tests are used to identify BRCA mutations This conversation is designed to help patients and caregivers better understand precision-based treatment options and the importance of appropriate testing when making informed cancer care decisions. ➡️ Learn more about RNA Sequencing:    • What is RNA Expression Testing? How Molecu...   👀 ➡️ Learn more about Tumor DNA Sequencing:    • Why Tumor DNA Sequencing (Tissue-Based) 🧬 ...   👀 Would you like further support with your cancer care? Let us help you and your doctor to access the newest, leading-edge diagnostics and treatments for your care. 🌿 Join our Free Daily Drop-in Zoom Calls with Michelle: https://lp.constantcontactpages.com/c... Book a free Cancer Care Consultation with our team: https://www.ctoam.com/free-strategy-s... Register for a Precision Second Opinion & Complete Treatment Options Review with expert Alex Rolland: https://www.ctoam.com/consultation Learn more about Alex: https://alexrolland.com 🧬 Download CTOAM’S Free Ebook Here: https://www.ctoam.com/ebook/ 📘 Join our (free) "Cancer Just the Facts" online program: 👉 https://cancerjustthefacts.com/ Get hundreds of free resources on Precision Cancer Medicine and access to our weekly Zoom calls with cancer experts. *** CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf. We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you. Other ways to stay in touch with CTOAM: Facebook:   / cancertreatmentoptionsandmanagement   LinkedIn:   / ctoam   Twitter:   / ctoam   Blog: https://research.ctoam.com/ LinkedIn (Liquid Biopsy Labs):   / 13063544   LBL Twitter:   / liquidbiopsynow   Disclaimer: Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.